Skip navigation

Cutting-Edge Frameworks for Compliant Program Design to Enhance Patient Access and Affordability

October 6-8, 2020
  • San Diego, CA

With mounting cost pressures and increased demands for affordable, value-based treatment options, bio/pharmaceutical teams face an increasingly competitive market, for both specialty and non-specialty products. Increasingly, industry must strategize to manage the most critical challenges associated with product and patient services.

CBI’s 15th Hub and SPP Model Optimization convenes key stakeholders including manufacturers, specialty pharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and maximized reimbursement.

Hear Expert Insights from a Leading Multi-Stakeholder Speaking Faculty on:

  • Explore leading strategies to mitigate risks for patient assistance and reimbursement support programs to ensure compliance
  • Maximize synergetic partnerships between key stakeholders including the Hub, manufacturer, specialty pharmacy, patient and more
  • Streamline the Hub to propel product success, create efficiencies and optimize patient access
  • Consider metrics and best practices for a continuous overall hub assessment for optimal performance
  • Analyze DOJ oversight of ePA and eBV data
  • Enhance electronic benefit verification and prior authorizations to optimize workflow
  • Hear advances in and best practices when considering/implementing innovative therapies and personalized medicine in an age of digitalization
  • Evaluate emerging hub models that align with strategic product objectives in a cost-effective manner
  • Leverage next-gen technology advancements including A.I
  • Hear cutting-edge advances driving an all-encompassing and state-of-the-art hub

Stay tuned for additional 2020 program details!

15th Hub and SPP Model Optimization

Cutting-Edge Frameworks for Compliant Program Design to Enhance Patient Access and Affordability

With mounting cost pressures and increased demands for affordable, value-based treatment options, bio/pharmaceutical teams face an increasingly competitive market, for both specialty and non-specialty products. Increasingly, industry must strategize to manage the most critical challenges associated with product and patient services.

CBI’s 15th Hub and SPP Model Optimization convenes key stakeholders including manufacturers, specialty pharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and maximized reimbursement.

Hear Expert Insights from a Leading Multi-Stakeholder Speaking Faculty on:

  • Explore leading strategies to mitigate risks for patient assistance and reimbursement support programs to ensure compliance
  • Maximize synergetic partnerships between key stakeholders including the Hub, manufacturer, specialty pharmacy, patient and more
  • Streamline the Hub to propel product success, create efficiencies and optimize patient access
  • Consider metrics and best practices for a continuous overall hub assessment for optimal performance
  • Analyze DOJ oversight of ePA and eBV data
  • Enhance electronic benefit verification and prior authorizations to optimize workflow
  • Hear advances in and best practices when considering/implementing innovative therapies and personalized medicine in an age of digitalization
  • Evaluate emerging hub models that align with strategic product objectives in a cost-effective manner
  • Leverage next-gen technology advancements including A.I
  • Hear cutting-edge advances driving an all-encompassing and state-of-the-art hub

Stay tuned for additional 2020 program details!